ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000273240.1	Ponatinib	Bladder urothelial carcinoma	0.026760896	Sensitive
ENSG00000273240.1	Ponatinib	Breast invasive carcinoma	0.022574905	Resistant